Vivanza Biosciences Q2 Results

  • BSE: 530057
  • NSE: -
  • ISIN: INE984E01035
  • Sector: Biotechnology & Drugs
BSE
1.890.01 (0.53%)
Volume17.68 K
Updated: Fri 11 Sep, 2026 | 15:15:00
NSE
This stock is not traded on NSE
Today: 1.88
1.90
52-Wk: 1.52
2.72

Q2 Results Highlights

Quarter ended Sep 25

    Note: Comparison is on QoQ basis

    Quarterly - Vivanza Biosciences Q2 Results

    *All figures in crores except per share values
    Fiscal PeriodSep 25Jun 26QoQ CompSep 24YoY Comp
    Total Operating Expense 54.769.37522.72%2.901791.05%
    Depreciation/ Amortization 0.000.010.00%0.00-14.63%
    Operating Income 0.60-0.08312.04%0.11473.17%
    Net Income 0.560.15547.01%0.023531.61%
    Other Operating Expenses Total 0.070.05-30.54%0.0465.59%
    Net Income Before Taxes 0.560.18547.01%0.023531.61%
    Total Revenue 55.369.29519.27%3.001744.89%
    Selling/ General/ Admin Expenses Total 0.250.1081.96%0.1480.77%
    Diluted Normalized EPS 0.140.04600.00%0.003508.25%
    Recommended For You

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe

        Trending Now In Market